Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CVS/Caremark May Have Less Formulary Adherence, Express Scripts Says

Executive Summary

CVS/Caremark's intention to be "agnostic" to whether prescriptions are filled by mail or retail could adversely affect the proposed entity's ability to manage members' formulary adherence, Express Scripts VP-Investor Relations David Myers suggested

You may also be interested in...



Express Scripts Tells Caremark Shareholders Vertical Mergers With PBMs Fail

A merger between pharmacy benefit manager Caremark and pharmacy chain CVS would be plagued by the same problems that vertical mergers involving PBMs have faced in the past, PBM Express Scripts argues in a pamphlet to Caremark shareholders

Express Scripts Tells Caremark Shareholders Vertical Mergers With PBMs Fail

A merger between pharmacy benefit manager Caremark and pharmacy chain CVS would be plagued by the same problems that vertical mergers involving PBMs have faced in the past, PBM Express Scripts argues in a pamphlet to Caremark shareholders

Medco Emerges As Big Winner In PBM Sweepstakes; Caremark Already Losing

Medco may be the biggest beneficiary of the bidding war between pharmacy chain CVS and pharmacy benefit manager Express Scripts for PBM Caremark

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047780

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel